Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Pamela A. Villalobos"'
Autor:
Long Qian, Steven Menez, David Hu, Jason Weinstein, Hannah Melchinger, Heather Thiessen-Philbrook, Randy L. Luciano, Jeffrey M. Turner, Mark A. Perazella, Celia Pamela Corona Villalobos, Melissa M. Shaw, F. Perry Wilson, Chirag R. Parikh, Dennis G. Moledina
Publikováno v:
Kidney360. 4:98-101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1102c59c97629de252704a7201a4638a
https://doi.org/10.34067/kid.0006602022
https://doi.org/10.34067/kid.0006602022
Autor:
Ethan Dmitrovsky, Sarah J. Freemantle, Xi Liu, Shanhu Hu, Fadzai Chinyengetere, John F. Hancock, Kwang-jin Cho, Masanori Kawakami, Jason Roszik, Samir M. Hanash, Hiroyuki Katayama, Ignacio Wistuba, Pamela Andrea Villalobos, Barbara Mino, Jaime Rodriguez-Canales, Vincent Memoli, Laura J. Tafe, Yun Lu, Lisa Maria Mustachio
KRAS is frequently mutated in lung cancers and is associated with aggressive biology and chemotherapy resistance. Therefore, innovative approaches are needed to treat these lung cancers. Prior work implicated the IFN-stimulated gene 15 (ISG15) deubiq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd5c9584958b0a004b044ec7e99060a1
https://doi.org/10.1158/1541-7786.c.6539967.v1
https://doi.org/10.1158/1541-7786.c.6539967.v1
Autor:
Don L. Gibbons, F. Xiao-Feng Qin, John V. Heymach, Ignacio I. Wistuba, Stephen E. Ullrich, Jing Wang, Ethan Dmitrovsky, Vassiliki A. Papadimitrakopoulou, Scott E. Woodman, Lauren Averett Byers, Masanori Kawakami, Jaime Rodriguez-Canales, Jingfen Zhu, Caleb A. Class, Youhong Fan, Carl M. Gay, Brett W. Carter, Weiyi Peng, Ferdinandos Skoulidis, Junna Oba, Pan Tong, Jonathon Roybal, Christin Ungewiss, David H. Peng, Jared J. Fradette, Di Peng, Qiang Zhao, Anfei Huang, Philip L. Lorenzi, Lin Tan, Xi Liu, Tina Cascone, Pamela A. Villalobos, Yanli Li, B. Leticia Rodriguez, Xiaohui Yi, Yongbin Yang, Lixia Diao, Limo Chen
Genes differentially expressed between IgG control and anti-PD-L1 treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c4546034d1bf67810222d236f67110
https://doi.org/10.1158/2159-8290.22532345
https://doi.org/10.1158/2159-8290.22532345
Autor:
Ethan Dmitrovsky, Sarah J. Freemantle, Xi Liu, Shanhu Hu, Fadzai Chinyengetere, John F. Hancock, Kwang-jin Cho, Masanori Kawakami, Jason Roszik, Samir M. Hanash, Hiroyuki Katayama, Ignacio Wistuba, Pamela Andrea Villalobos, Barbara Mino, Jaime Rodriguez-Canales, Vincent Memoli, Laura J. Tafe, Yun Lu, Lisa Maria Mustachio
Contains supplementary methods and supplementary figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f17e42720445f35f4ae273c7e9218d
https://doi.org/10.1158/1541-7786.22511532
https://doi.org/10.1158/1541-7786.22511532
Autor:
Ethan Dmitrovsky, Sarah J. Freemantle, Xi Liu, Shanhu Hu, Fadzai Chinyengetere, John F. Hancock, Kwang-jin Cho, Masanori Kawakami, Jason Roszik, Samir M. Hanash, Hiroyuki Katayama, Ignacio Wistuba, Pamela Andrea Villalobos, Barbara Mino, Jaime Rodriguez-Canales, Vincent Memoli, Laura J. Tafe, Yun Lu, Lisa Maria Mustachio
S1. Introduction of enzymatically-active USP18 overcomes growth inhibition of USP18-repressed lung cancer cells. S2. Loss of USP18 expression reduces growth of KRAS mutant human lung cancer cells. S3. Interferon (IFN) treatment of lung cancer cells h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434acfe4f00ac6e6251e1fe08b5626e4
https://doi.org/10.1158/1541-7786.22511535
https://doi.org/10.1158/1541-7786.22511535
Autor:
Don L. Gibbons, F. Xiao-Feng Qin, John V. Heymach, Ignacio I. Wistuba, Stephen E. Ullrich, Jing Wang, Ethan Dmitrovsky, Vassiliki A. Papadimitrakopoulou, Scott E. Woodman, Lauren Averett Byers, Masanori Kawakami, Jaime Rodriguez-Canales, Jingfen Zhu, Caleb A. Class, Youhong Fan, Carl M. Gay, Brett W. Carter, Weiyi Peng, Ferdinandos Skoulidis, Junna Oba, Pan Tong, Jonathon Roybal, Christin Ungewiss, David H. Peng, Jared J. Fradette, Di Peng, Qiang Zhao, Anfei Huang, Philip L. Lorenzi, Lin Tan, Xi Liu, Tina Cascone, Pamela A. Villalobos, Yanli Li, B. Leticia Rodriguez, Xiaohui Yi, Yongbin Yang, Lixia Diao, Limo Chen
Supplementary title page. Figure S1: CD38 on anti-PD-L1 resistant tumor cells is up-regulated, which is associated with tumor progression. Figure S2: anti-PD-L1 resistant tumors demonstrate the distinct mRNA and protein profiling for immune signature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496e18729d3c21e240505113f4e12cf2
https://doi.org/10.1158/2159-8290.22532348
https://doi.org/10.1158/2159-8290.22532348
Autor:
Sue-Hwa Lin, Gary E. Gallick, Francesc Posas, Eulalia de Nadal, Ignacio I. Wistuba, Pamela A. Villalobos, Jaime Rodriguez-Canales, Chad J. Creighton, Bin Liu, Kai-Jie Yu, Tianhong Pan, Jing Pan, Song-Chang Lin, Yu-Chen Lee, Guoyu Yu, Li-Yuan Yu-Lee
Intrabone p38DN tumor growth and cell proliferation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c2272f49299a999e75c420d45c686a4
https://doi.org/10.1158/0008-5472.22417107
https://doi.org/10.1158/0008-5472.22417107
Autor:
Sue-Hwa Lin, Gary E. Gallick, Francesc Posas, Eulalia de Nadal, Ignacio I. Wistuba, Pamela A. Villalobos, Jaime Rodriguez-Canales, Chad J. Creighton, Bin Liu, Kai-Jie Yu, Tianhong Pan, Jing Pan, Song-Chang Lin, Yu-Chen Lee, Guoyu Yu, Li-Yuan Yu-Lee
Gene array analysis of undifferentiated (Day 0) versus differentiated osteoblasts (Day 30 differentiation).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee7c0c994c421824b68f3b8faf4cc6e
https://doi.org/10.1158/0008-5472.22417098
https://doi.org/10.1158/0008-5472.22417098
Autor:
Sue-Hwa Lin, Gary E. Gallick, Francesc Posas, Eulalia de Nadal, Ignacio I. Wistuba, Pamela A. Villalobos, Jaime Rodriguez-Canales, Chad J. Creighton, Bin Liu, Kai-Jie Yu, Tianhong Pan, Jing Pan, Song-Chang Lin, Yu-Chen Lee, Guoyu Yu, Li-Yuan Yu-Lee
Bone metastasis from prostate cancer can occur years after prostatectomy, due to reactivation of dormant disseminated tumor cells (DTC) in the bone, yet the mechanism by which DTCs are initially induced into a dormant state in the bone remains to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b3098e33ec572b4d9b9359b39c61c71
https://doi.org/10.1158/0008-5472.c.6509742
https://doi.org/10.1158/0008-5472.c.6509742
Autor:
Angelique W. Whitehurst, John B. MacMillan, John D. Minna, Anthony J. Davis, Bruce A. Posner, Ignacio I. Wistuba, Jaime Rodriguez-Canales, Pamela A. Villalobos, Sydnie A. LaDuke, Prema L. Mallipeddi, Janapriya Saha, Min S. Kim, Jingsheng Yan, Kathleen McGlynn, Elizabeth A. McMillan, Nathaniel W. Oswald, Brandt A. Nichols
Figure S1- Piericidin A and HORMAD1 association identified by NPF screen; Figure S2- Piericidin A induces DNA damage in NSCLC lines; Figure S3- S2N and geneset overlaps for HORMAD1 high LUAD tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee52d7a62cbdfc6fd5c220bfb487a8e
https://doi.org/10.1158/0008-5472.22419254.v1
https://doi.org/10.1158/0008-5472.22419254.v1